|
Volumn 87, Issue 2, 2010, Pages 239-244
|
FDA regulation of dietary supplements and requirements regarding adverse event reporting
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HERBACEOUS AGENT;
NON PRESCRIPTION DRUG;
ACT;
BLOOD TOXICITY;
CONNECTIVE TISSUE DISEASE;
DIET SUPPLEMENTATION;
DRUG LABELING;
DRUG MANUFACTURE;
DRUG SAFETY;
ENDOCRINE DISEASE;
EYE DISEASE;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL TOXICITY;
GENITAL SYSTEM DISEASE;
GOOD MANUFACTURING PRACTICE;
HEALTH CARE PERSONNEL;
HEPATOBILIARY DISEASE;
HUMAN;
IMMUNOPATHOLOGY;
INFECTION;
INFESTATION;
INJECTION SITE REACTION;
INTOXICATION;
LYMPHATIC SYSTEM DISEASE;
MEDIASTINUM DISEASE;
MEDICAL INFORMATION;
MENTAL DISEASE;
MUSCULOSKELETAL DISEASE;
NEPHROTOXICITY;
NEUROTOXICITY;
NUTRITIONAL DISORDER;
POSTMARKETING SURVEILLANCE;
PREGNANCY COMPLICATION;
PRIORITY JOURNAL;
RELIABILITY;
RESPIRATORY TRACT DISEASE;
SHORT SURVEY;
SKIN TOXICITY;
UNITED STATES;
URINARY TRACT DISEASE;
VASCULAR DISEASE;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
DIETARY SUPPLEMENTS;
FOOD INDUSTRY;
FOOD LABELING;
HUMANS;
LEGISLATION, FOOD;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 75749101340
PISSN: 00099236
EISSN: 15326535
Source Type: Journal
DOI: 10.1038/clpt.2009.263 Document Type: Short Survey |
Times cited : (51)
|
References (2)
|